Geode Capital Management
DNTH icon

Geode Capital Management’s Dianthus Therapeutics DNTH Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$9.04M Sell
484,900
-32,118
-6% -$598K ﹤0.01% 2428
2025
Q1
$9.38M Buy
517,018
+30,755
+6% +$558K ﹤0.01% 2331
2024
Q4
$10.6M Buy
486,263
+1,142
+0.2% +$24.9K ﹤0.01% 2344
2024
Q3
$13.3M Sell
485,121
-13,799
-3% -$378K ﹤0.01% 2205
2024
Q2
$12.9M Buy
498,920
+424,520
+571% +$11M ﹤0.01% 2170
2024
Q1
$2.23M Buy
74,400
+29,221
+65% +$877K ﹤0.01% 3073
2023
Q4
$470K Buy
45,179
+18,838
+72% +$196K ﹤0.01% 3640
2023
Q3
$360K Sell
26,341
-331,349
-93% -$4.53M ﹤0.01% 3730
2023
Q2
$271K Hold
357,690
﹤0.01% 3904
2023
Q1
$284K Hold
357,690
﹤0.01% 3883
2022
Q4
$141K Buy
357,690
+7,254
+2% +$2.86K ﹤0.01% 4257
2022
Q3
$494K Buy
350,436
+6,566
+2% +$9.26K ﹤0.01% 3737
2022
Q2
$412K Sell
343,870
-249,419
-42% -$299K ﹤0.01% 3866
2022
Q1
$1.72M Buy
593,289
+41,351
+7% +$120K ﹤0.01% 3334
2021
Q4
$2.45M Buy
551,938
+23,664
+4% +$105K ﹤0.01% 3275
2021
Q3
$3.85M Buy
528,274
+25,083
+5% +$183K ﹤0.01% 3065
2021
Q2
$4.92M Buy
503,191
+99,393
+25% +$972K ﹤0.01% 2922
2021
Q1
$4.78M Buy
403,798
+115,904
+40% +$1.37M ﹤0.01% 2811
2020
Q4
$2.26M Sell
287,894
-537
-0.2% -$4.21K ﹤0.01% 3018
2020
Q3
$1.96M Buy
288,431
+8,510
+3% +$57.9K ﹤0.01% 2880
2020
Q2
$2.1M Buy
279,921
+8,886
+3% +$66.7K ﹤0.01% 2810
2020
Q1
$1.7M Buy
271,035
+12,395
+5% +$77.8K ﹤0.01% 2757
2019
Q4
$3.92M Buy
258,640
+15,141
+6% +$229K ﹤0.01% 2603
2019
Q3
$2.5M Buy
243,499
+3,207
+1% +$32.9K ﹤0.01% 2803
2019
Q2
$3.54M Buy
240,292
+119,354
+99% +$1.76M ﹤0.01% 2610
2019
Q1
$1.99M Buy
120,938
+99,199
+456% +$1.63M ﹤0.01% 2858
2018
Q4
$123K Buy
21,739
+6,525
+43% +$36.9K ﹤0.01% 3825
2018
Q3
$182K Buy
+15,214
New +$182K ﹤0.01% 3787